Company Description
Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide.
It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns, as well as food quality and nutritional components.
It also provides AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods.
The segment offers its products primarily to milling and grain, meat and poultry, prepared food products and ingredients, fruits and vegetables, seafood, dairy, beverage, water, healthcare, traditional culture media markets, food service, and dietary supplements markets.
The Animal Safety segment provides veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products, and genomics testing services marketed through veterinarians, retailers, livestock producers, and animal health product distributors, for the animal safety market.
The segment offers its products for companion animal veterinarians; livestock producers, veterinarians, and breed associations; retailers; breeding and genetics companies; diagnostic labs and universities; distributors; and other manufacturers and government agencies.
The company was incorporated in 1981 and is headquartered in Lansing, Michigan.
| Country | United States |
| Founded | 1981 |
| IPO Date | Aug 23, 1989 |
| Industry | Diagnostics & Research |
| Sector | Healthcare |
| Employees | 2,917 |
| CEO | John Adent |
Contact Details
Address: 620 Lesher Place Lansing, Michigan 48912-1595 United States | |
| Phone | 517 372 9200 |
| Website | neogen.com |
Stock Details
| Ticker Symbol | NEOG |
| Exchange | NASDAQ |
| Fiscal Year | June - May |
| Reporting Currency | USD |
| CIK Code | 0000711377 |
| CUSIP Number | 640491106 |
| ISIN Number | US6404911066 |
| Employer ID | 38-2367843 |
| SIC Code | 2835 |
Key Executives
| Name | Position |
|---|---|
| John Edward Adent | President, Chief Executive Officer and Director |
| David H. Naemura | Chief Financial Officer |
| Douglas E. Jones | Chief Operating Officer and Vice President |
| Amy M. Rocklin Ph.D. | Chief Legal and Compliance Officer and Corporate Secretary |
| John Moylan | Vice President, Corporate Controller and Chief Accounting Officer |
| Dr. Robert S. Donofrio Ph.D. | Vice President and Chief Scientific Officer |
| Sarah Demey | Administrative Manager |
| Bill Waelke | Head of Investor Relations |
| Julie A. Mann | Vice President and Chief Human Resources Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Nov 14, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
| Nov 14, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
| Nov 4, 2024 | SCHEDULE 13G | Filing |
| Oct 28, 2024 | 8-K | Current Report |
| Oct 10, 2024 | 10-Q | Quarterly Report |
| Oct 10, 2024 | 8-K | Current Report |
| Oct 10, 2024 | 8-K | Current Report |
| Oct 1, 2024 | 8-K | Current Report |
| Sep 13, 2024 | DEF 14A | Other definitive proxy statements |
| Sep 13, 2024 | ARS | Filing |